{"id":"https://openalex.org/W7225327687","doi":"https://doi.org/10.22551/2026.53.1304.10352","title":"Concurrent erythema multiforme and psoriasiform eruption during enfortumab vedotin plus pembrolizumab therapy for advanced urothelial carcinoma.","display_name":"Concurrent erythema multiforme and psoriasiform eruption during enfortumab vedotin plus pembrolizumab therapy for advanced urothelial carcinoma.","publication_year":2026,"publication_date":"2026-01-01","ids":{"openalex":"https://openalex.org/W7225327687","doi":"https://doi.org/10.22551/2026.53.1304.10352","pmid":"https://pubmed.ncbi.nlm.nih.gov/42985658","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13734327"},"language":"en","primary_location":{"id":"pmid:42985658","doi":"https://doi.org/10.22551/2026.53.1304.10352","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42985658","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archive of clinical cases","raw_type":"Case Reports"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13734327/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013035382","display_name":"Rossella Di Trolio","orcid":"https://orcid.org/0000-0003-1215-2602","observed_orcids":["https://orcid.org/0000-0003-1215-2602"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Rossella Di Trolio","raw_affiliation_strings":["Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori Istituto di Ricovero e Cura a Carattere Scientifico Fondazione G. Pascale, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori Istituto di Ricovero e Cura a Carattere Scientifico Fondazione G. Pascale, Naples, Italy","institution_ids":["https://openalex.org/I4210141868"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5055464636","display_name":"Giuseppe Di Lorenzo","orcid":"https://orcid.org/0000-0001-7414-1568","observed_orcids":["https://orcid.org/0000-0001-7414-1568"]},"institutions":[{"id":"https://openalex.org/I4210095444","display_name":"Saint Camillus International University of Health and Medical Sciences","ror":"https://ror.org/00qvkm315","country_code":"IT","type":"education","lineage":["https://openalex.org/I4210095444"]},{"id":"https://openalex.org/I4405255019","display_name":"Azienda Sanitaria Locale Salerno","ror":"https://ror.org/02gwsdp44","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4405255019"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giuseppe Di Lorenzo","raw_affiliation_strings":["School of Medicine, UniCamillus \"Saint Camillus International\" University of Health Sciences, Rome, Italy","Oncology Division, PO PAGANI, ASL SALERNO, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Medicine, UniCamillus \"Saint Camillus International\" University of Health Sciences, Rome, Italy","institution_ids":["https://openalex.org/I4210095444"]},{"raw_affiliation_string":"Oncology Division, PO PAGANI, ASL SALERNO, Italy","institution_ids":["https://openalex.org/I4405255019"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.88480529,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"13","issue":"4","first_page":"117","last_page":"121"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":0.9496999979019165,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":0.9496999979019165,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.027000000700354576,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.008299999870359898,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/erythema-multiforme","display_name":"erythema multiforme","score":0.9850000143051147},{"id":"https://openalex.org/keywords/psoriasiform-eruption","display_name":"psoriasiform eruption","score":0.9900000095367432},{"id":"https://openalex.org/keywords/enfortumab-vedotin","display_name":"enfortumab vedotin","score":0.9929999709129333},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":1.0},{"id":"https://openalex.org/keywords/urothelial-carcinoma","display_name":"urothelial carcinoma","score":0.921999990940094},{"id":"https://openalex.org/keywords/cutaneous-adverse-effects","display_name":"cutaneous adverse events","score":0.9440000057220459},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.5360000133514404},{"id":"https://openalex.org/keywords/plantar-lesions","display_name":"plantar lesions","score":0.6470000147819519},{"id":"https://openalex.org/keywords/corticosteroid-therapy","display_name":"corticosteroid therapy","score":0.8579999804496765},{"id":"https://openalex.org/keywords/clinicopathological-correlation","display_name":"clinicopathological correlation","score":0.777999997138977},{"id":"https://openalex.org/keywords/upper-tract-urothelial-carcinoma","display_name":"upper tract urothelial carcinoma","score":0.8500000238418579}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9401000142097473},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.8855999708175659},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.7391999959945679},{"id":"https://openalex.org/C2777793932","wikidata":"https://www.wikidata.org/wiki/Q1116229","display_name":"Common Terminology Criteria for Adverse Events","level":3,"score":0.6700000166893005},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.635200023651123},{"id":"https://openalex.org/C2779121184","wikidata":"https://www.wikidata.org/wiki/Q1166142","display_name":"Erythema","level":2,"score":0.6205000281333923},{"id":"https://openalex.org/C2781320243","wikidata":"https://www.wikidata.org/wiki/Q1363732","display_name":"Erythema multiforme","level":2,"score":0.5340999960899353},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.47029998898506165},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3986000120639801},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.37070000171661377},{"id":"https://openalex.org/C3019882237","wikidata":"https://www.wikidata.org/wiki/Q2501186","display_name":"Urothelial carcinoma","level":4,"score":0.35350000858306885},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.34709998965263367},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.3393000066280365},{"id":"https://openalex.org/C2777546739","wikidata":"https://www.wikidata.org/wiki/Q33525","display_name":"Carcinoma","level":2,"score":0.33709999918937683},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.31869998574256897},{"id":"https://openalex.org/C198451711","wikidata":"https://www.wikidata.org/wiki/Q327657","display_name":"Rheumatology","level":2,"score":0.3118000030517578},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.28110000491142273},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.27559998631477356},{"id":"https://openalex.org/C2777789703","wikidata":"https://www.wikidata.org/wiki/Q192102","display_name":"Skin cancer","level":3,"score":0.2741999924182892},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.26829999685287476},{"id":"https://openalex.org/C185926286","wikidata":"https://www.wikidata.org/wiki/Q1929812","display_name":"Systemic therapy","level":4,"score":0.2621999979019165},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.2522999942302704}],"mesh":[],"locations_count":2,"locations":[{"id":"pmid:42985658","doi":"https://doi.org/10.22551/2026.53.1304.10352","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42985658","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archive of clinical cases","raw_type":"Case Reports"},{"id":"pmh:oai:pubmedcentral.nih.gov:13734327","doi":"https://doi.org/10.22551/2026.53.1304.10352","is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13734327/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arch Clin Cases","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:13734327","doi":"https://doi.org/10.22551/2026.53.1304.10352","is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13734327/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arch Clin Cases","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7148974982","https://openalex.org/W4404792767","https://openalex.org/W4404826708","https://openalex.org/W4400694774","https://openalex.org/W7214534811","https://openalex.org/W4406917086","https://openalex.org/W4406211716","https://openalex.org/W4410822078","https://openalex.org/W7140997938","https://openalex.org/W7140134994"],"abstract_inverted_index":{"Enfortumab":[0],"vedotin":[1],"(EV)":[2],"plus":[3,49,103],"pembrolizumab":[4,104],"is":[5],"an":[6,164],"effective":[7],"first-line":[8],"treatment":[9,22,112,131],"for":[10,69],"advanced":[11],"urothelial":[12,34],"carcinoma,":[13],"but":[14],"clinically":[15,143],"significant":[16],"cutaneous":[17,75,145],"adverse":[18],"events":[19],"may":[20],"require":[21],"interruption":[23],"or":[24,167],"discontinuation.":[25],"We":[26],"report":[27],"a":[28,38,91],"74-year-old":[29],"man":[30],"with":[31],"metastatic":[32],"upper-tract":[33],"carcinoma":[35],"who":[36],"achieved":[37],"complete":[39,129],"metabolic":[40],"and":[41,54,82,107,109,127,150,160],"radiologic":[42],"response":[43],"after":[44],"three":[45],"cycles":[46,53],"of":[47,122,141,154],"EV":[48,102],"pembrolizumab.":[50],"After":[51],"six":[52],"before":[55],"cycle":[56],"7,":[57],"he":[58],"developed":[59],"painful":[60],"plantar":[61],"lesions":[62],"that":[63],"progressed":[64],"to":[65],"Common":[66],"Terminology":[67],"Criteria":[68],"Adverse":[70],"Events":[71],"(CTCAE)":[72],"grade":[73,124],"3":[74,125],"toxicity":[76,126],"involving":[77],"the":[78,99,123,138,152],"lower":[79],"limbs,":[80],"trunk,":[81],"oral":[83],"cavity.":[84],"Clinicopathological":[85],"assessment":[86],"supported":[87],"erythema":[88],"multiforme,":[89],"while":[90],"morphologically":[92],"distinct":[93,144],"psoriasiform":[94],"eruption":[95,165],"was":[96,105,132],"identified":[97],"on":[98],"upper":[100],"limbs.":[101],"discontinued,":[106],"systemic":[108],"topical":[110],"corticosteroid-based":[111],"produced":[113],"marked":[114],"improvement":[115],"within":[116],"approximately":[117],"one":[118],"month.":[119],"In":[120],"view":[121],"ongoing":[128],"response,":[130],"not":[133],"restarted.":[134],"This":[135],"case":[136],"highlights":[137],"uncommon":[139],"coexistence":[140],"two":[142],"patterns":[146],"during":[147],"combination":[148],"therapy":[149],"underscores":[151],"value":[153],"early":[155],"dermatologic":[156],"assessment,":[157],"clinicopathological":[158],"correlation,":[159],"multidisciplinary":[161],"management":[162],"when":[163],"evolves":[166],"displays":[168],"atypical":[169],"morphology.":[170]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-11-06T00:00:00"}
